Vantage Consulting Group’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Vantage Consulting Group's AMGN Position: Q3 2024 in Review
Vantage Consulting Group sold out of Amgen (AMGN) in Q3 2024, closing a stake of 785 shares — an estimated $245K sold.
Vantage Consulting Group first reported a position in AMGN in Q4 2020 and held it in 14 quarters. The position peaked at $278K in Q4 2021. 2,823 funds tracked by Wall St. Rank hold AMGN as of Q3 2024.
- Vantage Consulting Group reported no remaining Amgen position as of Q3 2024 after selling out during the quarter.
- Vantage Consulting Group sold 785 Amgen shares in Q3 2024, an estimated $245K.
- Vantage Consulting Group first reported a position in Amgen in Q4 2020 and held it in 14 quarters.
- Vantage Consulting Group's Amgen position peaked at $278K in Q4 2021.
- 2,823 funds tracked by Wall St. Rank held Amgen as of Q3 2024.
Based on Vantage Consulting Group's 13F filing for Q3 2024, filed 14 Nov 2024.